Initial management of candidemia at an academic medical center: Evaluation of the IDSA guidelines

Diagnostic Microbiology and Infectious Disease

Volumn 52, Issue 1, 2005, Pages 29-34

  Patel, Mukesh ^a   Kunz, Danielle F ^b   Trivedi, Vivek M ^a   Jones, Marga G ^a   Moser, Stephen A ^c   Baddley, John W ^a,d  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

^d BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

Candida; Candidemia; IDSA guidelines

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CASPOFUNGIN; FLUCONAZOLE; VORICONAZOLE;

ANTIBIOTIC THERAPY; CANDIDIASIS; CENTRAL VENOUS CATHETER; CONSULTATION; CONTROLLED STUDY; DRUG USE; FEMALE; HEALTH CARE ORGANIZATION; HEALTH SERVICE; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME; VALIDATION PROCESS;

EID: 18844457128     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2004.12.010     Document Type: Article

References (25)

1. E.J. Anaissie, J.H. Rex, Ö. Uzun, and S. Vartivarian Predictors of adverse outcome in cancer patients with candidemia Am. J. Med. 104 1998 238 245
2. J.W. Baddley, M. Patel, M. Jones, G. Cloud, A.C. Smith, and S.A. Moser Utility of real-time antifungal susceptibility testing for fluconazole in the treatment of candidemia Diagn. Microbiol. Infect. Dis. 50 2004 119 124
3. T. Buchner, W. Fegeler, H. Bernhardt, N. Brockmeyer, K.H. Duswald, M. Herrmann, D. Heuser, U. Jehn, G. Just-Nübling, M. Karthaus, G. Maschmeyer, F.M. Müller, J. Müller, J. Ritter, N. Roos, M. Ruhnke, A. Schmalreck, R. Schwarze, G. Schwesinger, and G. Silling Treatment of severe Candida infections in high-risk patients in Germany: Consensus formed by a panel of interdisciplinary investigators Eur. J. Clin. Microbiol. Infect. Dis. 21 2002 337 352
4. M.B. Edmond, S.E. Wallace, D.K. McKlish, M.A. Pfaller, R.N. Jones, and R.P. Wenzel Nosocomial bloodstream infections in United States hospitals: A three-year analysis Clin. Infect. Dis. 29 1999 239 244
5. J.E. Edwards, G.P. Bodey, R.A. Bouden, T. Büchner, B.E. de Pauw, S.G. Filler, M.A. Ghannoum, M. Glauser, R. Herbrecht, C.A. Kauffman, S. Kohno, P. Martino, F. Meunier, T. Mori, M.A. Pfaller, J.H. Rex, T.R. Rogers, R.H. Rubin, J. Solomkin, C. Viscoli, T.J. Walsh, and M. White International conference for the development of a consensus on the management and prevention of severe candidal infections Clin. Infect. Dis. 25 1997 43 59
6. V.G. Fowler, L.L. Sanders, D.J. Sexton, L. Kong, K.A. Marr, A.K. Gopal, G. Gottlieb, S. McClelland, and G.R. Corey Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious disease specialists: Experience with 244 patients Clin. Infect. Dis. 27 1998 478 486
7. B.C. Fox, P.B. Imrey, M.B. Voights, and S. Norwood Infectious disease consultation and microbiologic surveillance for intensive care unit trauma patients: A pilot study Clin. Infect. Dis. 33 2001 1981 1989
8. G.L. Fraser, P. Stogsdill, J.D. Dickens, D.E. Wennberg Jr, R.P. Smith Jr, and B.S. Prato Antibiotic optimization. An evaluation of patient safety and economic outcomes Arch. Intern. Med. 157 1997 1689 1694
9. J. Gomez, S.J. Conde Cavero, J.L. Hernandez Cardona, M.L. Nunez, J. Ruiz Gomez, M. Canteras, and M. Valdes The influence of the opinion of an infectious disease consultant on the appropriateness of antibiotic treatment in a general hospital J. Antimicrob. Chemother. 38 1996 309 314
10. O. Gudlaugsson, S. Gillespie, K. Lee, J.V. Berg, J. Hu, S. Messer, L. Herwaldt, M. Pfaller, and D. Diekema Attributable mortality of nosocomial candidemia, revisited Clin. Infect. Dis. 37 2003 1172 1177
11. B.E. Hirsch, A. Arunabh, A. Fein, A. Silver, and S. Merwin Role of infectious disease (ID) consultation for community acquired pneumonia (CAP) [Abstract 809] 39th Annual Meeting of the Infectious Diseases Society of America (IDSA) Oct 25-28, 2001 2001
12. A.S. Kao, M.E. Brandt, W.R. Pruitt, L.A. Conn, B.A. Perkins, D.S. Stephens, W.S. Baughman, A.L. Reingold, G.A. Rothrock, M.A. Pfaller, R.W. Pinner, and R.A. Hajjeh The epidemiology of candidemia in two United States cities: Results of a population-based active surveillance Clin. Infect. Dis. 29 1999 1164 1170
13. W.A. Knaus, E.A. Draper, D.P. Waner, and J.E. Zimmerman APACHE II: A severity of disease classification system Crit. Care Med. 13 1985 818 829
14. M. Nucci, and E. Anaissie Should vascular catheters be removed from all patients with candidemia? An evidence-based review Clin. Infect. Dis. 34 2002 591 599
15. P.G. Pappas, J.H. Rex, J. Lee, R.J. Hamill, R.A. Larsen, W. Powderly, C.A. Kauffman, N. Hyslop, J.E. Mangino, S. Chapman, H.W. Horowitz, J.E. Edwards, and W.E. Dismukes A prospective observation study of candidemia: Epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients Clin. Infect. Dis. 37 2003 634 643
16. P.G. Pappas, J.H. Rex, J.D. Sobel, S.G. Filler, W.E. Dismukes, T.J. Walsh, and J.E. Edwards Guidelines for treatment of candidiasis Clin. Infect. Dis. 38 2004 161 189
17. D. Pittet, N. Li, R.F. Woolson, and R.P. Wenzel Microbiological factors influencing the outcome of nosocomial bloodstream infections: A 6-year validated, population-based model Clin. Infect. Dis. 24 1997 1068 1078
18. M.S. Rangel-Frausto, T. Wilbin, H.M. Blumberg, L. Saiman, J. Patterson, M. Rinaldi, M. Pfaller, J.E. Edwards, W. Jarvis, J. Dawson, R.P. Wenzel NEMIS Study Group National Epidemiology of Mycoses Survey (NEMIS): Variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units Clin. Infect. Dis. 29 1999 253 258
19. A.M. Rentz, M.T. Halpern, and R.A. Bowden The impact of candidemia on length of hospital stay, outcome, and overall cost of illness Clin. Infect. Dis. 27 1998 781 788
20. J.H. Rex, T.J. Walsh, J.D. Sobel, S.G. Filler, P.G. Pappas, W.E. Dismukes, and J.E. Edwards Practice guidelines for the treatment of candidiasis Clin. Infect. Dis. 30 2000 662 678
21. W.E. Trick, S.K. Fridkin, J.R. Edwards, R.A. Hajjeh, R.P. Gaynes National Nosocomial Infections Surveillance System Hospitals Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999 Clin. Infect. Dis. 35 2002 627 630
22. B.J. Turner, L. McKee, T. Fanning, and L.E. Markson AIDS specialist versus generalist ambulatory care for advance HIV infection and impact on hospital use Med. Care 32 1994 902 916
23. C. Viscoli, C. Girmenia, A. Marinus, L. Collette, P. Martino, B. Vandercam, C. Doyen, B. Lebeau, D. Spence, V. Krcmery, B. De Pauw, F. Meunier Invasive Fungal Infection Group of the EORTC Candidemia in cancer patients: A prospective, multicenter surveillance study by the invasive fungal infection group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC) Clin. Infect. Dis. 28 1999 1071 1079
24. S.B. Wey, M. Mori, M.A. Pfaller, R.F. Woodson, and R.P. Wenzel Hospital-acquired candidemia. The attributable mortality and excess length of stay Arch. Intern. Med. 148 1988 2642 2645
25. H. Wisplinghoff, T. Bischoff, S.M. Tallent, H. Seifert, R.P. Wenzel, and M.B. Edmond Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study Clin. Infect. Dis. 39 2004 309 337